Low-density Lipoprotein Activates Jun N-terminal Kinase (JNK) in Human Endothelial Cells.

Y Zhu,Hl Liao,Np Wang,O Friedli,L Verna,Mb Stemerman
DOI: https://doi.org/10.1016/s0005-2760(98)00167-2
IF: 5.228
1999-01-01
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Abstract:We have reported previously that native low-density lipoprotein (LDL) activates c-Jun and transcription factor AP-1 in human umbilical vein endothelial cells (HUVEC). The aim of this study was to elucidate the upstream signaling mechanisms mediating LDL activation of c-Jun/AP-1. Using a c-Jun NH2-terminal kinase (JNK) activity assay, we have detected an increase in JNK activity in LDL-exposed HUVEC, which started at 15 min and reached maximum activity after 1–2 h. This JNK activity, increased by LDL, occurred in a dose-dependent fashion starting at a concentration of 80 mg/dl of LDL and reaching maximum activation at a concentration of 160–240 mg/dl. Following cotransfection, the increase of AP-1-driven luciferase activity by LDL was attenuated 54% by a kinase-deficient JNK1. Furthermore, a specific trans-reporting system was utilized to confirm c-Jun activation by upstream signal mechanisms. The results show c-Jun activity increased by 3-fold after LDL exposure when compared with respective controls. In contrast, LDL exposure did not affect the activation of extracellular signal regulated kinase 1 and 2 (ERK1/2), even though phorbol 12-myristate 13-acetate treatment remarkably increased the activity of these kinases. Thus, this study demonstrates, for the first time, that JNK mediates LDL-induced endothelial cell activation.
What problem does this paper attempt to address?